dementia

IDO1 Cancer Drugs Restarted Astrocyte Glucose In Alzheimer’s Models While Kisunla’s Cleared Plaques Held And England Still Haggles
Health News

IDO1 Cancer Drugs Restarted Astrocyte Glucose In Alzheimer’s Models While Kisunla’s Cleared Plaques Held And England Still Haggles

Kisunla, approved in July 2024, can be stopped once amyloid plaques clear, and extension data showed most reductions holding for up to three years. IDO1 cancer inhibitors restored astrocyte glucose…
Back to top button